NCR1 and metabolic dysfunction-associated steatotic liver disease: The patients with middle NAFLD had remarkably decreased NKp46+, NKG2D+, IFN-γ+, and GZB+ NK cells in the peripheral blood, demonstrating the compromised bioactivity of NK cells in individuals with fatty livers (Fig. 1A).